Evidence ledger

What is confirmed

  • Merck, Moderna claim 'promising' skin cancer vaccine results in key trial[1]
  • Merck, Moderna claim encouraging melanoma vaccine trial results[2]

What remains disputed or unverified

No disputed central claims are recorded for this story.

What is confirmed

Merck, Moderna claim 'promising' skin cancer vaccine results in key trial[1]

Merck, Moderna claim encouraging melanoma vaccine trial results[2]

Sources and ownership

This brief cites 2 reports from 2 sources (IOL section feed for News, South China Morning Post) under 2 separate ownership groups. Sources under separate ownership are less likely to repeat the same reporting error. Cited Current publishes a template brief only when an event is corroborated by at least 2 independently owned sources or by an official or wire report.[1][2]

First detected August 19, 2026 at 14:14 UTC; the earliest cited report was published August 19, 2026 at 14:10 UTC. All times are UTC.[1][2]

Version and update history
  1. Version 1 · — Initial source-grounded generation